Sources | Names Used |
---|---|
CTRPv2 | JQ-1:vorinostat (2:1 mol/mol) |
PharmacoGx | JQ-1:vorinostat (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCDC71L | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
mRNA | SYS1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | C1orf115 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | CNDP2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | ANKRD46 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | VAMP3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | TTC1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | ADAR | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | NME6 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | ASB16 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |